The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BSH 2019 | Infectious complications of CLL: prevention and treatment
Ben Kennedy, MB ChB, FRCP(UK), FRCPath, University Hospitals of Leicester NHS Trust, Leicester, tells us about the infectious complications of chronic lymphocytic leykemia (CLL) and the agents commonly used to treat it, highlighting what can be done to both avoid and address these issues. This interview took place at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.
